Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Efficacy of silicon-based agent against aging-related frailty
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 13 February 2026

Efficacy of silicon-based agent against aging-related frailty

  • Yoshihisa Koyama1,2,
  • Yuki Kobayashi3,
  • Hikaru Kobayashi3 &
  • …
  • Shoichi Shimada1,2 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Diseases
  • Health care
  • Medical research
  • Neuroscience

Abstract

Increasing aging populations globally have made maintaining a healthy life expectancy for older adults a critical issue. Older adults are particularly susceptible to frailty, physical and mental vulnerability caused by age-related decline in physiological and psychological resilience. Preventing its onset is essential for extending a healthy lifespan. Declines in antioxidant capacity contributes to frailty; therefore, administration of antioxidants may help prevent or treat this condition. Silicon (Si)-based agent reacts with water to produce hydrogen, which selectively scavenges deleterious reactive oxygen species. Oral Si-based agent administration can effectively alleviate symptoms in various disease models associated with oxidative stress, including Parkinson’s disease, ulcerative colitis, facial nerve palsy, and small intestinal ischemia–reperfusion injury. We investigated whether a Si-based agent could prevent or ameliorate frailty associated with aging using klotho mice, a premature aging model, and 105-week-old C57BL/6J mice. In klotho mice, the Si-based agent significantly alleviated age-related physical changes, including kyphosis and deterioration of coat conditions, and frailty-related somatic symptoms, including decreased spontaneous activity and motor function. Moreover, multicriteria frailty classification revealed fewer frail and pre-frail phenotypes in Si-based agent–treated klotho mice than in untreated mice. In aged C57BL/6J mice, the Si-based agent mitigated oxidative stress, suppressed motor performance and body weight decline, and reduced early mortality associated with age-related deterioration. Si-based agent may represent a potential strategy for combating frailty.

Similar content being viewed by others

Efficacy of the silicon based agent for age related decline in vestibular function

Article Open access 14 August 2025

Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents

Article Open access 27 April 2021

Association between conicity index and frailty in older Americans: the NHANES cross-sectional study, 2007–2018

Article Open access 22 May 2025

Data availability

All relevant data are included within this paper.

References

  1. Arai, H. Implication of frailty in elderly care. Japanese J. Geriatr. 51, 497–501 (2014).

    Google Scholar 

  2. Rockwood, K. & Howlett, S. E. Fifteen years of progress in Understanding frailty and health in aging. BMC Med. 16, 220. https://doi.org/10.1186/s12916-018-1223-3 (2018).

    Google Scholar 

  3. Fang, J. et al. Combining motivational and exercise intervention components to reverse pre-frailty and promote self-efficacy among community-dwelling pre-frail older adults: a randomized controlled trial. BMC Geriatr. 24, 896. https://doi.org/10.1186/s12877-024-05464-6 (2024).

    Google Scholar 

  4. Travers, J. et al. Building resilience and reversing frailty: a randomised controlled trial of a primary care intervention for older adults. Age Ageing https://doi.org/10.1093/ageing/afad012 (2023).

    Google Scholar 

  5. Yakabi, A. et al. A longitudinal study of frailty reversibility through a multi-component dementia prevention program. J. Phys. Ther. Sci. 37, 256–261. https://doi.org/10.1589/jpts.37.256 (2025).

    Google Scholar 

  6. Álvarez-Satta, M. et al. Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models. Aging (Albany NY). 12, 9982–9999. https://doi.org/10.18632/aging.103295 (2020).

    Google Scholar 

  7. Tembo, M. C. et al. Total antioxidant capacity and frailty in older men. Am. J. Mens Health. 14, 1557988320946592. https://doi.org/10.1177/1557988320946592 (2020).

    Google Scholar 

  8. Soysal, P. et al. Oxidative stress and frailty: A systematic review and synthesis of the best evidence. Maturitas 99, 66–72. https://doi.org/10.1016/j.maturitas.2017.01.006 (2017).

    Google Scholar 

  9. Kameda, M., Teruya, T., Yanagida, M. & Kondoh, H. Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility. Proc. Natl. Acad. Sci. U S A. 117, 9483–9489. https://doi.org/10.1073/pnas.1920795117 (2020).

    Google Scholar 

  10. Viña, J., Borras, C. & Gomez-Cabrera, M. C. A free radical theory of frailty. Free Radic Biol. Med. 124, 358–363. https://doi.org/10.1016/j.freeradbiomed.2018.06.028 (2018).

    Google Scholar 

  11. Kim, J. et al. Au nanozyme-driven antioxidation for preventing frailty. Colloids Surf. B Biointerfaces. 189, 110839. https://doi.org/10.1016/j.colsurfb.2020.110839 (2020).

    Google Scholar 

  12. Wang, D. et al. Correction to: Antioxidant apigenin relieves Age-Related muscle atrophy by inhibiting oxidative stress and hyperactive mitophagy and apoptosis in skeletal muscle of mice. J. Gerontol. Biol. Sci. Med. Sci. 77, 1173. https://doi.org/10.1093/gerona/glac086 (2022).

    Google Scholar 

  13. El Assar, M. & Angulo, J. Rodríguez-Mañas, L. Frailty as a phenotypic manifestation of underlying oxidative stress. Free Radic Biol. Med. 149, 72–77. https://doi.org/10.1016/j.freeradbiomed.2019.08.011 (2020).

    Google Scholar 

  14. Kobayashi, Y., Matsuda, S., Imamura, K. & Kobayashi, H. Hydrogen generation by reaction of Si nanopowder with neutral water. J. Nanopart. Res. 19, 176. https://doi.org/10.1007/s11051-017-3873-z (2017).

    Google Scholar 

  15. Kobayashi, Y. et al. Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent. Sci. Rep. 10, 5859. https://doi.org/10.1038/s41598-020-62755-9 (2020).

    Google Scholar 

  16. Koyama, Y. et al. A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent. Sci. Rep. 12, 9634. https://doi.org/10.1038/s41598-022-13655-7 (2022).

    Google Scholar 

  17. Koyama, Y. et al. Therapeutic strategy for facial paralysis based on the combined application of Si-based agent and methylcobalamin. Biochem. Biophys. Rep. 32, 101388. https://doi.org/10.1016/j.bbrep.2022.101388 (2022).

    Google Scholar 

  18. Shimada, M., Koyama, Y., Kobayashi, Y., Kobayashi, H. & Shimada, S. Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis. Sci. Rep. 13, 5707. https://doi.org/10.1038/s41598-023-32745-8 (2023).

    Google Scholar 

  19. Shimada, M. et al. Si-based agent alleviated small bowel ischemia-reperfusion injury through antioxidant effects. Sci. Rep. 14, 4141. https://doi.org/10.1038/s41598-024-54542-7 (2024).

    Google Scholar 

  20. Harada, S. et al. Efficacy of the silicon based agent for age related decline in vestibular function. Sci. Rep. 15, 29790. https://doi.org/10.1038/s41598-025-14302-7 (2025).

    Google Scholar 

  21. Kuro-o, M. et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51. https://doi.org/10.1038/36285 (1997).

    Google Scholar 

  22. Kurosu, H. et al. Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833. https://doi.org/10.1126/science.1112766 (2005).

    Google Scholar 

  23. Sahu, A. et al. Age-related declines in α-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration. Nat. Commun. 9, 4859. https://doi.org/10.1038/s41467-018-07253-3 (2018).

    Google Scholar 

  24. Baumann, C. W., Kwak, D. & Thompson, L. V. Assessing onset, prevalence and survival in mice using a frailty phenotype. Aging (Albany NY). 10, 4042–4053. https://doi.org/10.18632/aging.101692 (2018).

    Google Scholar 

  25. Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. Biol. Sci. Med. Sci. 56, M146–M156. https://doi.org/10.1093/gerona/56.3.M146 (2001).

    Google Scholar 

  26. Saio, V., Kharbuli, Z., Ratnakaran, N., Marquez, M. & Chakraborty, A. Amelioration of age-dependent increase in oxidative stress markers in male mice by extract of Potentilla fulgens. Redox Rep. 21, 130–138 (2016).

    Google Scholar 

  27. Lim, J., Luderer, U. & Lipshultz, L. I. Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary. Aging Cell. 10, 278–291 (2011).

    Google Scholar 

  28. Nakatsukasa, T. et al. Pathological analysis of age-related bladder dysfunction. Kawasaki Med. J. 49, 57–67 (2023).

    Google Scholar 

  29. Yamamoto, M. et al. Regulation of oxidative stress by the anti-aging hormone Klotho. J. Biol. Chem. 280, 38029–38034. https://doi.org/10.1074/jbc.M509039200 (2005).

    Google Scholar 

  30. Hsieh, C. C., Kuro-o, M., Rosenblatt, K. P., Brobey, R. & Papaconstantinou, J. The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY). 2, 597–611. https://doi.org/10.18632/aging.100194 (2010).

    Google Scholar 

  31. Li-Zhen, L., Chen, Z. C., Wang, S. S., Liu, W. B. & Zhuang, X. D. Klotho deficiency causes cardiac ageing by impairing autophagic and activating apoptotic activity. Eur. J. Pharmacol. 911, 174559. https://doi.org/10.1016/j.ejphar.2021.174559 (2021).

    Google Scholar 

  32. Nguyen, B. T. et al. Ginsenoside re attenuates memory impairments in aged Klotho deficient mice via interactive modulations of angiotensin II AT1 receptor, Nrf2 and GPx-1 gene. Free Radic Biol. Med. 189, 2–19. https://doi.org/10.1016/j.freeradbiomed.2022.07.003 (2022).

    Google Scholar 

  33. Moos, W. H. et al. Klotho Pathways, myelination Disorders, neurodegenerative Diseases, and epigenetic drugs. Biores Open. Access. 9, 94–105. https://doi.org/10.1089/biores.2020.0004 (2020).

    Google Scholar 

  34. Liguori, I. et al. Oxidative stress, aging, and diseases. Clin. Interv Aging. 13, 757–772. https://doi.org/10.2147/CIA.S158513 (2018).

    Google Scholar 

  35. Sahu, A. et al. Age-related declines in α-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration. Nat. Commun. 9, 4859. https://doi.org/10.1038/s41467-018-07253-3 (2018).

    Google Scholar 

  36. Nagai, T. et al. Cognition impairment in the genetic model of aging Klotho gene mutant mice: a role of oxidative stress. FASEB J. 17, 50–52. https://doi.org/10.1096/fj.02-0448fje (2003).

    Google Scholar 

  37. Shin, E. J. et al. Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential. Int. J. Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyu105 (2014).

    Google Scholar 

  38. Nguyen, B. T. et al. Theanine attenuates memory impairments induced by Klotho gene depletion in mice. Food Funct. 10, 325–332. https://doi.org/10.1039/c8fo01577e (2019).

    Google Scholar 

  39. Bose, C. et al. Iron chelation prevents Age-Related skeletal muscle sarcopenia in Klotho gene mutant Mice, a genetic model of aging. J. Cachexia Sarcopenia Muscle. 16, e13678. https://doi.org/10.1002/jcsm.13678 (2025).

    Google Scholar 

  40. Ohsawa, I. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 13, 688–694. https://doi.org/10.1038/nm1577 (2007).

    Google Scholar 

  41. Bean, L. A. et al. Klotho deficiency promotes skeletal muscle weakness and is associated with impaired motor unit connectivity. Int. J. Mol. Sci. 26, 7986. https://doi.org/10.3390/ijms26167986 (2025).

    Google Scholar 

  42. Yuan, N. et al. Hearing analysis in heterozygous and homozygous Klotho gene-deficient mice. J. Otol. 13, 131–134. https://doi.org/10.1016/j.joto.2018.04.001 (2018).

    Google Scholar 

  43. Crawley, J. N. What’s Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice 2nd edn. (Wiley, 2007).

    Google Scholar 

  44. Whitehead, J. C. et al. A clinical frailty index in aging mice: comparisons with frailty index data in humans. J. Gerontol. Biol. Sci. Med. Sci. 69, 621–632. https://doi.org/10.1093/gerona/glt136 (2014).

    Google Scholar 

  45. Kane, A. E. et al. Animal models of frailty: current applications in clinical research. Clin. Interv Aging. 11, 1519–1529. https://doi.org/10.2147/CIA.S105714 (2016).

    Google Scholar 

  46. Kane, A. E. et al. Impact of longevity interventions on a validated mouse clinical frailty index. J. Gerontol. Biol. Sci. Med. Sci. 71, 333–339. https://doi.org/10.1093/gerona/glu315 (2016).

    Google Scholar 

  47. Graber, T. G., Ferguson-Stegall, L., Liu, H. & Thompson, L. V. Voluntary aerobic exercise reverses frailty in old mice. J. Gerontol. Biol. Sci. Med. Sci. 70, 1045–1058. https://doi.org/10.1093/gerona/glu163 (2015).

    Google Scholar 

  48. Pajski, M. L. et al. Endurance exercise preserves physical function in adult and older male C57BL/6 mice: high intensity interval training (HIIT). Front. Aging. 5, 1356954. https://doi.org/10.3389/fragi.2024.1356954 (2024).

    Google Scholar 

  49. Bronikowski, A. M. et al. Lifelong voluntary exercise in the mouse prevents age-related alterations in gene expression in the heart. Physiol. Genomics. 12, 129–138. https://doi.org/10.1152/physiolgenomics.00082.2002 (2003).

    Google Scholar 

  50. Navarro, A., Gomez, C., López-Cepero, J. M. & Boveris, A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R505–511. https://doi.org/10.1152/ajpregu.00208.2003 (2004).

    Google Scholar 

  51. Garcia-Valles, R. et al. Life-long spontaneous exercise does not prolong lifespan but improves health span in mice. Longev. Healthspan. 2, 14. https://doi.org/10.1186/2046-2395-2-14 (2013).

    Google Scholar 

  52. Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256. https://doi.org/10.1038/s41591-018-0092-9 (2018).

    Google Scholar 

  53. Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192. https://doi.org/10.1038/ncomms3192 (2013).

    Google Scholar 

  54. Kane, A. E. et al. Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. BioRxiv https://doi.org/10.1101/2024.06.21.599604 (2024).

    Google Scholar 

  55. Mills, K. F. et al. Long-Term administration of nicotinamide mononucleotide mitigates Age-Associated physiological decline in mice. Cell. Metab. 24, 795–806. https://doi.org/10.1016/j.cmet.2016.09.013 (2016).

    Google Scholar 

  56. Xun, Z. M. et al. Effects of long-term hydrogen intervention on the physiological function of rats. Sci. Rep. 10, 18509. https://doi.org/10.1038/s41598-020-75492-w (2020).

    Google Scholar 

  57. Conti, V. et al. Antioxidant supplementation in the treatment of aging-associated diseases. Front. Pharmacol. 7, 24. https://doi.org/10.3389/fphar.2016.00024 (2016).

    Google Scholar 

  58. Meulmeester, F. L. et al. Antioxidant supplementation in oxidative stress-related diseases: what have we learned from studies on alpha-tocopherol?. Antioxidants 11, 2322. https://doi.org/10.3390/antiox11122322 (2022).

    Google Scholar 

  59. Shen, H. W. et al. Humanized Transgenic mouse models for drug metabolism and Pharmacokinetic research. Curr. Drug Metab. 12, 997–1006. https://doi.org/10.2174/138920011798062265 (2011).

    Google Scholar 

  60. Lanske, B. & Razzaque, M. S. Premature aging in Klotho mutant mice: cause or consequence? Ageing Res. Rev. 6, 73–79. https://doi.org/10.1016/j.arr.2007.02.002 (2007).

    Google Scholar 

  61. Nabeshima, Y. Klotho deficient mouse: an in vivo model for human aging. Drug Discov Today Dis. Models. 1, 223–227. https://doi.org/10.1016/j.ddmod.2004.11.023 (2004).

    Google Scholar 

  62. Harada, S. et al. A mouse model of autoimmune inner ear disease without endolymphatic hydrops. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167198. https://doi.org/10.1016/j.bbadis.2024.167198 (2024).

    Google Scholar 

Download references

Acknowledgements

This research was supported by the Center of Innovation Program (COI Program, Grant Number JPMJCE1310, JST Japan. We would like to thank Editage (www.editage.com) for English language editing, Nagahama Bio Science Laboratory belong to Oriental Yeast Co., Ltd. for the serum biochemical analyses, and the Center for Medical Research and Education, Graduate School for Medicine, Osaka University, for technical support.

Funding

This work was supported by Center of Innovation Program (COI Program) Grant Number JPMJCE1310, JST Japan.

Author information

Authors and Affiliations

  1. Department of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Osaka, 565-0871, Osaka, Japan

    Yoshihisa Koyama & Shoichi Shimada

  2. Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka, 541-8567, Japan

    Yoshihisa Koyama & Shoichi Shimada

  3. SANKEN, The University of Osaka, Osaka, 567-0047, Japan

    Yuki Kobayashi & Hikaru Kobayashi

Authors
  1. Yoshihisa Koyama
    View author publications

    Search author on:PubMed Google Scholar

  2. Yuki Kobayashi
    View author publications

    Search author on:PubMed Google Scholar

  3. Hikaru Kobayashi
    View author publications

    Search author on:PubMed Google Scholar

  4. Shoichi Shimada
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Yo.K. designed the study, analyzed the data, and wrote the paper. Yu.K. and H.K. developed the method for fabrication of Si-based agent. S.S. supervised this study and provided intellectual directions. All authors discussed the findings and commented on this manuscript.

Corresponding author

Correspondence to Yoshihisa Koyama.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Supplementary Material 4

Supplementary Material 5

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koyama, Y., Kobayashi, Y., Kobayashi, H. et al. Efficacy of silicon-based agent against aging-related frailty. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39711-0

Download citation

  • Received: 08 December 2025

  • Accepted: 06 February 2026

  • Published: 13 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-39711-0

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Frailty
  • Si-based agent
  • Klotho
  • Aging
  • Oxidative stress
Supplementary Material 2Supplementary Material 3Supplementary Material 4
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing